Recent News

By Category: International

Yellow fever vaccination booster not needed

(WHO) The yellow fever ‘booster’ vaccination given ten years after the initial vaccination is not necessary, according to WHO. An article published in WHO’s Weekly Epidemiological Record (WER) reveals that the Organization’s Strategic Advisory Group of Experts on immunization (SAGE) has reviewed the latest evidence and concluded that a single dose of vaccination is sufficient Read More »

May 22, 2013
| Filed under International, Public Health, and Research
Share

Legal status of GMO probe team queried

(Daily Nation: Kenya) The legality of a taskforce investigating the safety of genetically modified crops has been cast into doubt. Concerns have arisen that its members were not legally constituted as they have not been gazetted, in line with government requirements. As a result, Kenyans might not have a chance to have findings from the Read More »

May 22, 2013
| Filed under Agriculture and International
Share

Development underway for first transgenic sugarcane plantation

(The Jakarta Post) The National Genetically Modified Product Biosafety Commission (KKHPRG) recently approved the first genetically-altered sugarcane crop, paving the way for the development of transgenic sugarcane for commercial production. Bambang Purwantara, a member of the commission, said that the institutions which held the mandate to approve biotech plants had all given the nod to Read More »

May 22, 2013
| Filed under Agriculture, Biosafety, and International
Share

Singapore’s First Home-Grown Influenza Vaccine In Phase 1 Clinical Trial

(Medical News Today) Singapore’s Agency for Science, Technology and Research (A*STAR) and Switzerland’s Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos’ proprietary bacteriophage Qbeta virus-like particle (VLP) technology.

May 22, 2013
| Filed under International and Research
Share

NAMRU-3 Researchers Collaborate on Dengue Prevention

(Global Biodefense) The U.S. Naval Medical Research Unit No. 3 (NAMRU-3) initiated a new project for efficient and sustained control of dengue vectors in Lahore, Pakistan. The emergence of dengue and dengue hemorrhagic fever is considered a major public health threat there.